American Brain Tumor Association
Events Care & Support Donate Tumor Info About Us Home Home

January 2012

ABTA Tab

ABTA Sponsors Brain Tumor Clinical Practice Guideline

The American Brain Tumor Association is partnering with the American Association of Neuroscience Nurses to produce new nursing clincal guidelines for brain tumor patients. "Clinical Practice Guideline: Care of the Patient with a Brain Tumor” will include assessment and management of common brain tumor symptoms, treatment side effects, care plans for both adult and pediatric brain tumor patients, and more. The guidelines, which will help to ensure the highest standard of safe and effective care to patients with brain tumors, will be available in print format and online through both organizations in 2013.

 

ABTA and Oncology Nursing Society Foundation Accepting Applications for Neuro-Oncology Nursing Research Grant
This $10,000 grant award is designed to support oncology nursing research conducted by beginning and experienced researchers. These small grants are for neuro-oncology nursing research, pain assessment and management or certifications, nursing education and/or outcomes research. The award is funded by the American Brain Tumor Association, and administered by the Oncology Nursing Society Foundation Small Grants Program. Click here for more information 

 

 

Register Now for the Breakthrough for Brain Tumors Chicago 5K Run/Walk

Breakthrough for Brain Tumors Splash

Registration is now open for the Breakthrough for Brain Tumors Chicago 5K. Visit our new website at www.breakthroughforbraintumors.org to register as an individual participant or a team, receive fundraising and event information, and learn about new features of our event. If you have any questions, please contact one of our Event Coordinators at (800) 886-1281 or events@abta.org. We look forward to you joining us as we make breakthroughs for brain tumors in 2012.

 

Team Breakthrough: Helping the ABTA Move Forward

Team Breakthrough Logo

The ABTA is also expanding its endurance running program, Team Breakthrough, in 2012.  Team Breakthrough trains with a purpose – to help improve, extend and ultimately save the lives of the 600,000 people living with brain tumors in the U.S. Interested in joining Team Breakthrough at the Bank of America Chicago Marathon? Register at www.abtateambreakthrough.org through Wednesday, January 18 using promo code RUNCHI and receive a $26.20 discount on registration. Contact Alisha Kassam at akassam@abta.org or (773) 577-8763 for more information.

 

 

Meet the ZBTA: Zimbabwe Brain Tumor Association
Christine Mungoshi is a mother on a mission. When her daughter was diagnosed with a brain tumor in 2003, she refused to settle for just what was available to her. A resident of Harare, Zimbabwe, she searched for more resources, found the American Brain Tumor Association and called half way around the world for more information and support. Now, with her determination and some help from the ABTA, Ms. Mungoshi has formed the Zimbabwe Brain Tumor Association, to help brain tumor patients and caregivers on her side of the world. Click here to read more.
 

  tab patient care

Save the Dates for the 2012 Annual Patient-Family Meeting & Retreat
When
: July 27 - 29, 2012
Where: Renaissance Chicago O'Hare Suites Hotel - 8500 West Bryn Mawr Avenue, Chicago, Illinois 60631
 

Topics for our 2012 event will include understanding brain tumors, updates on research, quality of life and care giving, treatment information and much more.  We are also again offering a support group facilitator training on Friday, July 27. Registration information will be forthcoming.  

 

New Year Resolutions for Caregivers
Do you make resolutions this time of year? If you’re a caregiver for someone with a brain tumor, resolve to take care of yourself this year.  Think of care giving for someone with a brain tumor not as a sprint but as a marathon that requires a healthy lifestyle for the body, mind and spirit.  Click here to read 10 resolutions for caregivers in 2012.  

 

tab research news

 

Improved Treatments for Brain Cancers Highlighted at Annual Society of Neuro-Oncology (SNO) Meeting 
1400 neuro-oncologist and other cancer health care professionals gathered recently at the annual Society of Neuro-Oncology (SNO) Meeting to learn about advances made in the past year. Many of the most promising approaches were in the areas of immunotherapy and vaccines. Click here to read more.

 


Agent Shows  Ability to Suppress Brain Metastases and Related Damage
Scientists are one step closer to figuring out and repairing the damage caused by brain metastases. This area has been a challenging one for neuro-oncologists and researchers, and understanding the mechanisms and effects of brain metastases can help manage both patient care and treatment. Click here to read more.

 

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients with Brain MetastasesThe Graded Prognostic Assessment (GPA) is a prognostic index for patients with brain metastases. A database of over 3900 people with newly diagnosed brain metastases underwent analyses of prognostic factors association with outcomes by primary site and treatment. Click here to read more.

 

 

AboutABTA.gif

Founded in 1973, the American Brain Tumor Association was the first national nonprofit organization dedicated solely to funding brain tumor research and providing patients and families with brain tumor information and resources. For nearly 40 years, the Chicago-based ABTA has been providing critical funding to researchers working toward breakthroughs in brain tumor diagnosis, treatment and care, and is the only national organization serving the complex supportive care needs of brain tumor patients and caregivers.

Make a donation to the American Brain Tumor Association.

This information is provided by the American Brain Tumor Association, 8550 W. Bryn Mawr Ave., Suite 550, Chicago, Illinois, 60631. For more information on the American Brain Tumor Association, call toll-free: 1.800.886.ABTA (2282), write ABTAcares@abta.org, or visit www.abta.org. 

"American Brain Tumor Association" and "TrialConnect" are registered trademarks of the American Brain Tumor Association. The ABTA logo and "Where compassion meets commitment" tagline, the "Breakthrough for Brain Tumors" name and logo, and the "Team Breakthrough" name and logo are trademarks of the American Brain Tumor Association. All rights reserved.

Update Email Preferences | Forward to a Friend | Unsubscribe
©2012 American Brain Tumor Association

 connections_new.JPG FaceBook trialconnect_icon.JPG Twitter [object Object] 



Interested in
hosting an ABTA event? Contact us at events@abta.org.


Discover Community Support with ABTA Connections

ConnectionsHomepageNewFlash_July2011.JPG

Our Connections Online Support Community links patients, families, friends, caregivers and health care professionals with each other for support and inspiration. The online community was created to provide a safe place to visit, join and interact with over 400 members of the brain tumor community nationally and around the world.

Find a Clinical Trial Through TrialConnect
The American Brain Tumor Association offers a service that links brain tumor patients with appropriate clinical trials based on tumor type and treatment history. TrialConnect, a free and confidential service administered by EmergingMed, is offered in English and Spanish. Read more.

Consultation Services
Trained Care Consultants who provide brain tumor information, support and education for patients, families and health care professionals are available via email at
abtacares@abta.org  
or by calling our toll-free CareLine at 1-800-886-ABTA (2282).
 


 
   
   
This communication is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. The links set out on this communication are provided for your convenience only. The American Brain Tumor Association does not endorse the information contained on the linked Web sites or individual(s)/companies/institutions operating these websites.